Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Three tailored devices to ease the complex PCI procedures

14 May 2024 – From EuroPCR 2024

At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...

Three tailored devices to ease the complex PCI procedures

Bioresorbable scaffolds - new evidence and clinical applications

09 May 2024

Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!

Bioresorbable scaffolds - new evidence and clinical applications

Treating patients with drug-coated balloons – what is the optimal result?

12 Apr 2024

Watch this webinar with F. L. Ribichini, F. Alfonso, C. C. Frankie Tam and A. G. Zaman on how to prepare lesions for drug-coated ballons-based PCI and much more!

Treating patients with drug-coated balloons – what is the optimal result?

How did Dotter's method make its way to Europe and result in Andreas Grüntzig’s balloon catheter?

In this episode, Chiara De Biase and Jean Marco discuss how Eberhard Zeitler, inspired by Dotter's work, introduced the method in Germany. Grüntzig, known for his solid medical background and empathetic demeanor, received crucial support from colleagues. His determination, teamwork, and commitment led to the development of a flexible...

How did Dotter's method make its way to Europe and result in Andreas Grüntzig’s balloon catheter?

Quantitative coronary angiography vs intravascular ultrasonography to guide drug-eluting stent implantation - a randomized clinical trial

21 Mar 2024

The trial aimed to establish the non-inferiority of QCA-guided PCI compared to IVUS-guided PCI with respect to the primary endpoint of TLF at 12 months, defined as a composite of cardiac death, target vessel MI, or ischemia-driven target lesion revascularization.

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti

Reviewer

Salvatore Brugaletta
QCA vs IVUS to guide DES implantation - a randomized clinical trial

Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.

In this second episode, they highlight three key reasons for Charles Dotter's failure to spread his method widely in the...

Why was Dotter's disruptive innovation initially rejected?

Bioresorbable scaffolds - back to the future? Pros and Cons

14 Mar 2024

Watch the replay of this webinar with E. Barbato, A. Baumbach and M. Sabate. Understand the evolution process of bioresorbable scaffold technology and much more.

Bioresorbable scaffolds - back to the future? Pros and Cons

Minimal-metal PCI: a drug-coated balloon philosophy combined with selective lesion stenting where necessary - the hybrid approach

13 Mar 2024

Watch the replay of this webinar with P. O'Kane, D. Pan and H. Routledge to understand what factors during PCI lead to the switch from DCB to DES and much more!

Minimal-metal PCI

A journey with Charles Dotter: his contribution to transluminal angioplasty

In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.

In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...

A journey with Charles Dotter: his contribution to transluminal angioplasty

Why and when to use DCB?

06 Mar 2024

Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.

Why and when to use DCB?